Balyasny Asset Management
MGNX icon

Balyasny Asset Management’s MacroGenics MGNX Stock Holding History

Balyasny Asset Management’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-58,997
Closed -$868K – 2903
2024
Q1 		$868K Buy
58,997
+20,050
+51% +$303K ﹤0.01% 1855
2023
Q4 		$375K Buy
38,947
+27,695
+246% +$191K ﹤0.01% 2075
2023
Q3 		$52.4K Sell
11,252
-23,810
-68% -$119K ﹤0.01% 2157
2023
Q2 		$188K Buy
+35,062
New +$216K ﹤0.01% 2077
2023
Q1 		– Sell
-23,244
Closed -$156K – 2960
2022
Q4 		$156K Sell
23,244
-3,418
-13% -$18.7K ﹤0.01% 2181
2022
Q3 		$92K Sell
26,662
-8,337
-24% -$31.9K ﹤0.01% 2411
2022
Q2 		$103K Buy
+34,999
New +$184K ﹤0.01% 2278
2021
Q2 		– Sell
-127,866
Closed -$4.07M – 2193
2021
Q1 		$4.07M Buy
+127,866
New +$3.11M 0.02% 767
2020
Q4 		– Sell
-79,563
Closed -$2M – 1556
2020
Q3 		$2M Buy
+79,563
New +$2.17M 0.01% 833
2019
Q3 		– Sell
-73,311
Closed -$1.24M – 1411
2019
Q2 		$1.24M Buy
+73,311
New +$1.26M 0.01% 1018
2018
Q3 		– Sell
-19,772
Closed -$408K – 1900
2018
Q2 		$408K Buy
+19,772
New +$445K ﹤0.01% 1411
2017
Q1 		– Sell
-61,827
Closed -$1.26M – 1714
2016
Q4 		$1.26M Sell
61,827
-118,173
-66% -$2.97M 0.01% 959
2016
Q3 		$5.38M Buy
180,000
+30,000
+20% +$892K 0.03% 488
2016
Q2 		$4.05M Buy
150,000
+30,000
+25% +$677K 0.03% 553
2016
Q1 		$2.25M Sell
120,000
-15,271
-11% -$291K 0.01% 674
2015
Q4 		$4.19M Sell
135,271
-470,160
-78% -$14.3M 0.03% 535
2015
Q3 		$13M Buy
605,431
+599,931
+10,908% +$18.8M 0.1% 280
2015
Q2 		$209K Buy
+5,500
New +$181K ﹤0.01% 1012

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Balyasny Asset Management's MGNX Position: Q2 2024 in Review

Balyasny Asset Management sold out of MacroGenics (MGNX) in Q2 2024, closing a stake of 58,997 shares — an estimated $868K sold.

Balyasny Asset Management first reported a position in MGNX in Q2 2015 and held it in 18 quarters. The position peaked at $13M in Q3 2015. 146 funds tracked by Wall St. Rank hold MGNX as of Q2 2024.

  • Balyasny Asset Management reported no remaining MacroGenics position as of Q2 2024 after selling out during the quarter.
  • Balyasny Asset Management sold 58,997 MacroGenics shares in Q2 2024, an estimated $868K.
  • Balyasny Asset Management first reported a position in MacroGenics in Q2 2015 and held it in 18 quarters.
  • Balyasny Asset Management's MacroGenics position peaked at $13M in Q3 2015.
  • 146 funds tracked by Wall St. Rank held MacroGenics as of Q2 2024.

Based on Balyasny Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.